We read with interest the article ‘Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review’ by Makuloluwa et al. [1]. The article states that expert opinion is to stop anti-thrombotic medication (antiplatelet and anticoagulants) in patients undergoing lacrimal, deep orbital surgery or eyelid procedures as these are high risk for sight threatening haemorrhagic complications.

We report the findings of our prospective audit of patients on anti-thrombotics undergoing oculoplastic, lacrimal and orbital surgery at a single centre (Kings College London, UK) between September 2018 and September 2019. All procedures used cold steel techniques, diathermy with no post-operative padding. The incidence of postoperative haematoma formation was calculated using electronic records (Medisoft, Leeds UK) and cross-checked using post-operative photographs.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD